Hyperoxygenated solution for improved oxygen supply in patients undergoing lung lavage for pulmonary alveolar proteinosis

• Published in: Chinese medical journal Vol. 122; no. 15; pp. 1780 - 1783
• Main Authors: Zhou, Bin, Zhou, Hai-yan, Xu, Pei-hua, Wang, Hong-mei, Lin, Xian-ming, Wang, Xuan-ding
• Format: Journal Article
• Language: English
• Published: China Department of Anesthesiology,Second Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang 310009,China%Department of Respiratory Disease,Second Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang 310009,China 05.08.2009
• Subjects: Bronchoalveolar Lavage - methods; Female; Humans; Male; Middle Aged; Oxygen - therapeutic use; Pulmonary Alveolar Proteinosis - therapy; Sodium Chloride - therapeutic use; Treatment Outcome; 氧气供应; 沉积; 肺泡; 蛋白; 高氧; oxygen; bronchoalveolar lavage; pulmonary alveolar proteinosis
• ISSN: 0366-6999; 2542-5641; 2542-5641
• DOI: 10.3760/cma.j.issn.0366-6999.2009.15.012

Background At present, the most effective treatment for pulmonary alveolar proteinosis （PAP） remains whole-lung lavage in spite of the usually accompanying severe hypoxemia, which is expected to be prevented by hyperoxygenated solution improving oxygen supply during lavage. In this study, the efficacy and safety of the effect of hyperoxygenated solution were evaluated. Methods Five patients underwent whole-lung lavage over a 28-month period. Each lung was lavaged with hyperoxygenated （HO） and normal saline solution （plain lactated Ringer＇s solution, NO） randomly and alternatively until the reclaimed fluid was clear. Random number was generated by computer before every cycle of lavage. If the number was odd, the patient was assigned to receive a lavage cycle with hyperoxygenated solution （HO group, n=-109）; if the number was even, normal saline solution was used （NO group, n=-115）. Data of saturation of peripheral oxygen （SPO2）, mean arterial pressure （MAP）, central venous pressure （CVP）, heart rate （HR） and end-tidal carbon dioxide tension （PETCO2） were taken down at 0, 30, 60, 90, 120, 150, 180, 210 and 240 seconds from the beginning of the instillation of solution, and frequency and volume of unilateral lung lavage were also recorded. Time interval between the leR and the right lung lavage was 1 week. Results No patient was withdrawn from the study due to low SPO2 or leakage. Oxygen pressure was （730.21±7.43） mmHg in the hyperoxygenated solution against （175.73±5.92） mmHg in the normal saline solution （P 〈0.01）. Compared with baseline, 8PO2 increased significantly as the instillation of solution began （P〈0.01）, leveled for about 30 seconds （P 〉0.05）, and then decreased significantly to the lowest at the time of drainage （compared with 120 seconds or peak, P 〈0.01）. SPO2 was higher in HO group than in NO group （P 〈0.01）. There were no significant differences in MAP, HR, CVP and PETCO2 between HO group and NO group （P 〉0.05） and also among different time points （P 〉0.05）. Conclusion During the lung lavage for pulmonary alveolar proteinosis, hyperoxygenated solution could significantly improve oxygen supply in comparison with normal saline solution without obvious side effects.